Recall Register

Food, drugs, devices › Medacta Usa Inc

Device recall: NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platfor

FDA enforcement event 91091 · Class II · initiated 27 Oct 2022 · status Terminated · terminated 23 Oct 2023

DeviceVoluntary: Firm initiated1 product recordMemphis, TN

FDA enforcement event 91091 is a device recall by Medacta Usa Inc of Memphis, TN, initiated 27 Oct 2022 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 839 device enforcement events initiated in 2022 carry the same class.

Status: Terminated, terminated 23 Oct 2023. Initiation: voluntary: firm initiated. Medacta Usa Inc has 12 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Medacta Usa Inc, Memphis, TN.

Reason for recall

"A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid…"

Distribution

"AL, FL, NH, CO, IL, SC, AR"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0372-2023NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a reverse shoulder arthroplasty on the glenoid14 unitsClass IITerminated14 Dec 2022

Context

88%of 2022 device events are Class II839 events that year
1product record in this eventfirm median: 1
12events on this register for the firm

Other enforcement events for Medacta Usa Inc

InitiatedProduct (first record)TypeClassRecords
30 Apr 2026Short Monobloc Stem Broaches, Size/REF: 7/04.01.10.0970, 8/04.01.10.0971, 9/04.01.10.0972, 10/04.01.10.0973, 11/04.01.10DeviceClass II1
8 Mar 2023MectaLIF ANTERIOR - Lag Plate Flush H10, REF 03.30.300, interbody fusion deviceDeviceClass II6
13 Apr 2022GMK Efficiency - GMK Sphere CR Insert Instrument Set Size 1DeviceClass II1
4 Nov 2019Medacta Shoulder SYSTEM HUMERAL ANATOMICAL METAPHYSIS, REF 04.01.0023 through 04.01.0055, all sizes - Product Usage: TheDeviceClass II1
15 Nov 2017Medacta International MiniMAX CEMENTLESS ANATOMICAL STEM, 12/14: for cementless use in total or partial hip arthroplastyDeviceClass II1
24 Oct 2017The GMK knee system: designed for cemented use in total knee arthroplasty. Sphere and Primary Inserts with part number rDeviceClass II1
19 May 2017Medacta GMK HINGE, Tibial Insert Fixed, SIZE 2, HEIGHT 23 mm, REF 02.09.0223H, STERILE EODeviceClass II1
7 Dec 2016Medacta International SA, M.U.S.T. Rod, REF 03.50.433, Size 5.5mm, Length 480mm, Type Straight, Mat Co-Cr-Mo The rods acDeviceClass II1
17 Dec 2012Medacta Quadra Trial Broach size 0 part # 01.10.10.045, for use with the Medacta Total Hip Prosthesis System. Product UsDeviceClass II1
15 Jan 2010Versafitcup Impacting Ring Model Number: 01.26.10.0133 (46mm), 01.26.10.0134 (48mm), 01.26.10.0135 (50mm), 01.26.10.0136DeviceClass II1

All 12 events for Medacta Usa Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid…"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "AL, FL, NH, CO, IL, SC, AR"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 23 Oct 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.